I agree that this site is using cookies. You can find further informations here.
X
Eichhorst, Barbara
208  results:
Search for persons X
?
1

Fludarabine, cyclophosphamide, and rituximab as first‐line ..:

Kutsch, Nadine ; Giza, Adam ; Robrecht, Sandra...
European Journal of Haematology.  113 (2024)  2 - p. 235-241 , 2024
Link: https://doi.org/10.1111/..
 
?
2

Six-year follow-up and subgroup analyses of a phase 2 trial..:

Stilgenbauer, Stephan ; Tausch, Eugen ; Roberts, Andrew W....
Blood Advances.  8 (2024)  8 - p. 1992-2004 , 2024
Link: https://doi.org/10.1182/..
 
?
3

Bendamustine, followed by obinutuzumab and idelalisib in ch..:

Cramer, Paula ; von Tresckow, Julia ; Fink, Anna‐Maria...
American Journal of Hematology.  99 (2024)  6 - p. 1192-1195 , 2024
Link: https://doi.org/10.1002/..
 
?
4

Infections in patients with chronic lymphocytic leukemia tr..:

Langerbeins, Petra ; Giza, Adam ; Robrecht, Sandra...
American Journal of Hematology.  , 2024
Link: https://doi.org/10.1002/..
 
?
5

Plain language summary of zanubrutinib or ibrutinib in chro..:

Brown, Jennifer R ; Eichhorst, Barbara ; Hillmen, Peter...
Future Oncology.  20 (2024)  12 - p. 717-726 , 2024
Link: https://doi.org/10.2217/..
 
?
6

Hybrid immunity to SARS‐CoV‐2 in patients with chronic lymp..:

Mellinghoff, Sibylle C. ; Robrecht, Sandra ; Sprute, Rosanne...
European Journal of Haematology.  112 (2024)  5 - p. 788-793 , 2024
Link: https://doi.org/10.1111/..
 
?
7

Special issue on chronic lymphocytic leukemia: Prognosticat..:

Eichhorst, Barbara ; ten Hacken, Elisa
Seminars in Hematology.  61 (2024)  2 - p. 69-72 , 2024
Link: https://doi.org/10.1053/..
 
?
8

Updates on the biology of chronic lymphocytic leukemia: int..:

ten Hacken, Elisa ; Eichhorst, Barbara
Seminars in Hematology.  61 (2024)  3 - p. 139-141 , 2024
Link: https://doi.org/10.1053/..
 
?
9

S200: IBRUTINIB VERSUS PLACEBO IN PATIENTS WITH ASYMPTOMATI..:

Langerbeins, Petra ; Robrecht, Sandra ; Nieper, Pascal...
HemaSphere.  7 (2023)  S3 - p. e9488123 , 2023
Link: https://doi.org/10.1097/..
 
?
10

Author Correction: Transcriptomic profiles and 5-year resul..:

Al-Sawaf, Othman ; Zhang, Can ; Jin, Hyun Yong...
Nature Communications.  14 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
11

Transcriptomic profiles and 5-year results from the randomi..:

Al-Sawaf, Othman ; Zhang, Can ; Jin, Hyun Yong...
Nature Communications.  14 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
12

P640: ZANUBRUTINIB VS IBRUTINIB IN RELAPSED/REFRACTORY CHRO..:

Eichhorst, Barbara ; Lamanna, Nicole ; O'brien, Susan...
HemaSphere.  7 (2023)  S3 - p. e02428b9 , 2023
Link: https://doi.org/10.1097/..
 
?
13

P647: RACIAL DISPARITIES IN REAL-WORLD TREATMENT PATTERNS A..:

Rhodes, Joanna ; Shadman, Mazyar ; Lamanna, Nicole...
HemaSphere.  7 (2023)  S3 - p. e96103aa , 2023
Link: https://doi.org/10.1097/..
 
?
14

Treatment with idelalisib in patients with chronic lymphocy..:

von Tresckow, Julia ; Heyl, Nikola ; Robrecht, Sandra...
Annals of Hematology.  102 (2023)  11 - p. 3083-3090 , 2023
Link: https://doi.org/10.1007/..
 
?
15

S145: VENETOCLAX-OBINUTUZUMAB FOR PREVIOUSLY UNTREATED CHRO..:

Al-Sawaf, Othman ; Robrecht, Sandra ; Zhang, Can...
HemaSphere.  7 (2023)  S3 - p. e064430a , 2023
Link: https://doi.org/10.1097/..
 
1-15